ES515365A0 - Un procedimiento para la preparacion de un derivado de furanocremona. - Google Patents

Un procedimiento para la preparacion de un derivado de furanocremona.

Info

Publication number
ES515365A0
ES515365A0 ES515365A ES515365A ES515365A0 ES 515365 A0 ES515365 A0 ES 515365A0 ES 515365 A ES515365 A ES 515365A ES 515365 A ES515365 A ES 515365A ES 515365 A0 ES515365 A0 ES 515365A0
Authority
ES
Spain
Prior art keywords
furanocremona
derivative
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515365A
Other languages
English (en)
Other versions
ES8400442A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THIEMANN CHEM PHARM FAB
Original Assignee
THIEMANN CHEM PHARM FAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THIEMANN CHEM PHARM FAB filed Critical THIEMANN CHEM PHARM FAB
Publication of ES515365A0 publication Critical patent/ES515365A0/es
Publication of ES8400442A1 publication Critical patent/ES8400442A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES515365A 1981-08-31 1982-08-30 Un procedimiento para la preparacion de un derivado de furanocremona. Expired ES8400442A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813134364 DE3134364A1 (de) 1981-08-31 1981-08-31 Furano-chromon-verbindungen, verfahren zu ihrer herstellung und solche verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES515365A0 true ES515365A0 (es) 1983-11-01
ES8400442A1 ES8400442A1 (es) 1983-11-01

Family

ID=6140505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515365A Expired ES8400442A1 (es) 1981-08-31 1982-08-30 Un procedimiento para la preparacion de un derivado de furanocremona.

Country Status (9)

Country Link
EP (1) EP0074138A1 (es)
JP (1) JPS5846090A (es)
AU (1) AU8718882A (es)
DE (1) DE3134364A1 (es)
DK (1) DK366282A (es)
ES (1) ES8400442A1 (es)
FI (1) FI822980L (es)
GR (1) GR76904B (es)
ZA (1) ZA825824B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3571439D1 (en) * 1984-01-26 1989-08-17 Fisons Plc Benzopyran derivatives, compositions containing them and processes for their preparation
AUPS110302A0 (en) * 2002-03-14 2002-04-18 Biomolecular Research Institute Limited Novel chalcone derivatives and uses thereof
US8309545B2 (en) 2006-10-04 2012-11-13 Bionomics Limited Benzofuran potassium channel blockers and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR46M (es) * 1959-07-30 1960-11-28
US4313883A (en) * 1980-01-28 1982-02-02 The Upjohn Company Halofurochromones

Also Published As

Publication number Publication date
GR76904B (es) 1984-09-04
AU8718882A (en) 1983-03-10
FI822980A0 (fi) 1982-08-27
EP0074138A1 (en) 1983-03-16
FI822980L (fi) 1983-03-01
DE3134364A1 (de) 1983-03-10
DK366282A (da) 1983-03-01
ZA825824B (en) 1983-07-27
JPS5846090A (ja) 1983-03-17
ES8400442A1 (es) 1983-11-01

Similar Documents

Publication Publication Date Title
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES518225A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES517222A0 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES516825A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES514992A0 (es) Un procedimiento para la preparacion de un derivado carbostirilo.
ES510067A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoilurea.
ES522386A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES518975A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina.
ES509312A0 (es) Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES518294A0 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES522459A0 (es) Un procedimiento para la preparacion de un derivado de ascoclorina.
ES514263A0 (es) Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.
ES514213A0 (es) Un procedimiento para la preparacion de nuevos derivados poliprenilicos.
ES508775A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.
ES517852A0 (es) Un procedimiento para la preparacion de derivados de bencenosulfonamidas.
ES521021A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES520078A0 (es) Un procedimiento para la preparacion de un derivado de b -lactama.
ES515365A0 (es) Un procedimiento para la preparacion de un derivado de furanocremona.
ES514864A0 (es) Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida.